Objectives: Medication-related osteonecrosis of the jaws (MRONJ) is a serious condition whose risk factors remain unclear. The aim of this study is to investigate the role of oral health and of dental treatment in the development of MRONJ. Materials and methods: A case-control study was conducted in Brisbane, Australia. Hospital records were used to identify incident cases of MRONJ between January 2010 and March 2017. Cases were individually matched to up to 3 controls according to age, sex, primary disease, and type of antiresorptive therapy. Demographic data, medical histories and public dental records were collected. Associations between oral health, dental treatment, and MRONJ were investigated using conditional logistic regression. Res...
A retrospective analysis was performed with the aim of understanding whether the risk factors showed...
Objectives Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, and ...
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who ha...
Medication-related osteonecrosis of the jaws (MRONJ) is a serious condition whose risk factors remai...
AIMS: The primary objective was to assess the occurrence rate of Medication-Related OsteoNecrosis o...
Abstract Tooth extraction has been avoided since it has been considered a major risk factor for medi...
Background: Medication-related osteonecrosis of the jaws (MRONJ) is a mucosal lesion of the maxillof...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
Background: Medication related osteonecrosis of the jaw (MRONJ), is a rare adverse effect of anti-re...
Medication-related osteonecrosis of the jaws (MRONJ) has multiple exogenous and endogenous risk fact...
Purpose: Tooth and root extractions represent trigger factors for medication-related osteonecrosis o...
ObjectiveThe aim of this study was to investigate the relationship between type of antiresorptive me...
OBJECTIVES: Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, an...
BACKGROUND AND AIMS:Little is currently known about the risk of developing bisphosphonate-related os...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that is becoming mo...
A retrospective analysis was performed with the aim of understanding whether the risk factors showed...
Objectives Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, and ...
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who ha...
Medication-related osteonecrosis of the jaws (MRONJ) is a serious condition whose risk factors remai...
AIMS: The primary objective was to assess the occurrence rate of Medication-Related OsteoNecrosis o...
Abstract Tooth extraction has been avoided since it has been considered a major risk factor for medi...
Background: Medication-related osteonecrosis of the jaws (MRONJ) is a mucosal lesion of the maxillof...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
Background: Medication related osteonecrosis of the jaw (MRONJ), is a rare adverse effect of anti-re...
Medication-related osteonecrosis of the jaws (MRONJ) has multiple exogenous and endogenous risk fact...
Purpose: Tooth and root extractions represent trigger factors for medication-related osteonecrosis o...
ObjectiveThe aim of this study was to investigate the relationship between type of antiresorptive me...
OBJECTIVES: Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, an...
BACKGROUND AND AIMS:Little is currently known about the risk of developing bisphosphonate-related os...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that is becoming mo...
A retrospective analysis was performed with the aim of understanding whether the risk factors showed...
Objectives Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, and ...
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who ha...